News

Breakthrough drug helps rare obesity condition. Other research uncertain amid cuts.
A new drug is helping families who've spent years padlocking fridges, chaining garbage cans, and hiding food as their ...
Stoke Therapeutics: Impressive Pipeline And Big Backers
Ultimately, Stoke Therapeutics is that classic “intriguing biotech” --hurdling to one of those proverbial “moments of truth” ...
Cantor Fitzgerald Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)
Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.
US Appeals Court Confirms Patent Validity of Acadia’s Parkinson’s Medication
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is among the 13 Biotech Stocks with Huge Upside Potential. It declared that the U.S ...
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...
ACADIA Pharmaceuticals (ACAD) Receives a Buy from Canaccord Genuity
Detailed price information for Acadia Pharmaceutica (ACAD-Q) from The Globe and Mail including charting and trades.
US appeals court upholds Acadia’s patent for Parkinson’s drug in MSN Labs case
US Court of Appeals upholds Acadia Pharmaceuticals' patent for Nuplazid, securing protection against generic competition ...
EconoTimes6d
Acadia Secures Nuplazid Patent Protection Through 2038 After Appeals Court Ruling
Acadia Pharmaceuticals (NASDAQ: ACAD) announced that the U.S. Court of Appeals has upheld the validity of its patent for ...
US appeals court confirms patent validity of Acadia's Parkinson's drug
Acadia Pharmaceuticals said on Monday that the U.S. Court of Appeals has confirmed the validity of its patent for Nuplazid, ...
Acadia Pharmaceuticals Gets Another Court Win for Parkinson's Treatment
Acadia Pharmaceuticals has scored a second court win in less than a month that protects patents for its Parkinson's Disease treatment Nuplazid. The biopharmaceutical company said Monday that a federal ...